Enzo Biochem Inc. - Aset Bersih saben Siji Saham ENZ

Enzo Biochem, Inc. (ENZ) maintains business stability through reagent sales and strict cost control following the divestiture of its laboratories. An extensive DNA labeling patent portfolio serves as a defense against fierce competition. However, geopolitical fragmentation hinders test exports and scientific exchange. Changes in BVPS demonstrate capital resilience, with 0.89 representing the current level of this metric.

ENZ: Nilai Aset Bersih saben Saham Enzo 04.07.2022 - 26.04.2025

Enzo Biochem Inc. - rincian analitis lan metrik utama (ENZ)

- rega lan prakiraan konsensus rega:

Kutipan saham Enzo|ENZ - Bagan tingkat prakiraan

- data kapitalisasi pasar:

Nilai pasar Enzo Biochem, Inc.|ENZ - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham Enzo Biochem|ENZ - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku enzo.com|ENZ - Total Aset Bisnis

- data utang lan likuiditas:

Total Utang marang Modal Enzo Biochem, Inc.|ENZ - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Enzo|ENZ - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Enzo Biochem, Inc.

Analisis kabeh metrik perusahaan:enzo.com (ENZ)

It is critical for investors to determine whether the current market price justifies the actual asset value of Enzo Biochem, Inc. (ENZ) amid operational risks. When analyzing the projected book value per share, one must evaluate net equity minus liabilities, which in this instance confirms the effectiveness of business diversification between diagnostic services and the commercialization of biotechnological patents.

Analisis pesaing Enzo Biochem, Inc.